Nanoform Finland Oyj (FRA:4YL)

Market Cap	58.94M -38.8%
Revenue (ttm)	5.53M +39.8%
Net Income	-13.74M
EPS	-0.16
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.7090
Previous Close	0.7500
Day's Range	0.7090 - 0.7090
52-Week Range	0.4135 - 1.2160
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 19, 2026

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and dosage forms of Nanoparticles. It also offers STARMAP, an AI platform predic...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 108
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4YL

Financial Performance

In 2025, Nanoform Finland Oyj's revenue was 5.02 million, an increase of 37.10% compared to the previous year's 3.66 million. Losses were -17.90 million, -23.60% less than in 2024.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 15, 2026

Data Sources Report a data error